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Vitamin D is known for its role in the regulation of gene expression via the vitamin D receptor, a nuclear
transcription factor. More recently, a role for vitamin D in regulating DNA methylation has been iden-
tiﬁed as an additional mechanism of modulation of gene expression. How methylation status inﬂuences
vitamin D metabolism and response pathways is not yet clear. Therefore, we aimed to assess the rela-
tionship between plasma 25-hydroxycholecalciferol (25(OH)D) and the methylation status of vitamin D
metabolism enzyme genes (CYP2R1, CYP27B1 and CYP24A1) and the vitamin D receptor gene (VDR). This
analysis was conducted in the context of dietary vitamin D, and background methyl donor related
biochemistry, with adjustment for several dietary and lifestyle variables. Percentage methylation at CpG
sites was assessed in peripheral blood cells using methylation sensitive and dependent enzymes and
qPCR. Standard analytical techniques were used to determine plasma 25(OH)D and homocysteine, and
serum folate and B12, with the relationship to methylation status assessed using multi-variable
regression analysis. CYP2R1 and VDR methylation were found to be independent predictors of plasma
25(OH)D, when adjusted for vitamin D intake and other lifestyle variables. CYP24A1 was related to
plasma 25(OH)D directly, but not in the context of vitamin D intake. Methyl-group donor biochemistry
was associated with the methylation status of some genes, but did not alter the relationship between
methylation and plasma 25(OH)D. Modulation of methylation status of CYP2R1, CYP24A1 and VDR in
response to plasma 25(OH)D may be part of feedback loops involved in maintaining vitamin D ho-
meostasis, and may explain a portion of the variance in plasma 25(OH)D levels in response to intake and
sun exposure. Methyl-group donor biochemistry, while a potential independent modulator, did not alter
this effect.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).lecalciferol; 25(OH)D, 25-
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The active vitamin D metabolite, 1,25-dihydroxycholecalciferol
(1,25(OH)D; calcitriol), is well known for its inﬂuence on gene
regulation via its action on the vitamin D receptor (VDR), which
acts as a nuclear transcription factor [1]. However, the potential for
vitamin D to modulate gene expression indirectly, through modu-
lation of epigenetic marks is now also being investigated [2]. A
better understanding of the relationship between vitamin D status
and modulation of DNA methylation may help to explain some ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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inﬂuence of vitamin D status on disease risk. This may be particu-
larly important in elderly populations, in which vitamin D deﬁ-
ciency is common and who may be at higher risk of diseases linked
to suboptimal vitamin D status including osteoporosis [6], diabetes
[7], cardiovascular disease [8], autoimmune disease [9] and some
cancers [10e13].
The metabolism of vitamin D is a multistep process involving
several enzymes. Ergocalciferol (vitamin D2; from dietary sources)
and cholecalciferol (vitamin D3; from dietary sources and endog-
enous synthesis in the skin) are converted by calciol-25-
hydroxylase (coded for by the gene CYP2R1) into 25-
hydroxycholecaliferol (25(OH)D; calcidiol), which is the circu-
lating storage form of the vitamin. Calcidiol-1a-hydroxylase
(CYP27B1 gene) then converts 25(OH)D into 1,25(OH)D, the bio-
logically active ligand for the VDR [14,15]. A 24-hydroxylase
enzyme (CYP24A1 gene) is responsible for the inactivation of both
25(OH)D and 1,25(OH)D via hydroxylation [15] (Fig. 1).
Each of the genes encoding enzymes involved in the vitamin D
metabolism pathway is potentially regulated by DNA methylation.
DNAmethylation occurs at CpG sites (cytosine residues followed by
guanine residues), and clusters of CpGs are referred to as CpG
islands. Differential methylation of these islands in promotor re-
gions of genes may modulate gene expression, with hyper-
methylation often associated with decreased expression, and
hypo-methylation associated with increased expression [16]. VDR,
CYP2R1 and CYP24A1 each have CpG islands spanning their pro-
motor regions, and CYP27B1 has a CpG island in the gene body
(http://genome.ucsc.edu/) [2,17]. Vitamin D stimulation has also
been shown to inﬂuence global methylation markers [18], and to
alter the methylation status of multiple genes in multiple path-
ways, including those related to cell cycle regulation [19e22].
Therefore, DNA methylation and vitamin D metabolism may have a
complex and bidirectional relationship.
In a small (22 African American male youths) genome-wide
association study using DNA from blood leukocytes Zhu and col-
leagues identiﬁed a small differential methylation in CYP2R1 and
CYP24A1 between those with severe vitamin D deﬁciency,
compared to vitamin D sufﬁcient individuals [19]. However, it
should be noted that the statistical signiﬁcance of these results did
not survive corrections for multiple testing. Vitamin D deﬁcient
participants had higher methylation of CYP2R1 and lower methyl-
ation of CYP24A1. This study was purely observational, and the di-
rection of effect cannot be determined, however, following the
standard paradigm of increased methylation leading to reducedFig. 1. Simpliﬁed ﬂow chart of vitamin D metabolism. CYP2R1 is the gene for the
enzyme calciol-25-hydroxylase; CYP27B1 is the gene for the enzyme Calcidiol-1a-
hydroxylase; CYP24A1 is the gene for the 24-hydroxylase enzyme; VDR is the gene for
the vitamin D receptor.gene expression, this pattern of methylation may lead to a situation
where methylation status contributes to vitamin D deﬁciency, by
decreasing conversion into the active metabolite, and increasing
inactivation [19]. However an important limitation of this study
was the lack of adjustment for sun exposure or vitamin D intake.
More recently, Zhou and colleagues, in a study of vitamin D
supplementation in post-menopausal women, investigated
methylation status of CYP2R1, CYP24A1 and CYP27B1 DNA isolated
from serum [23]. In a preliminary binary analysis of 36 subjects,
methylation status of responders (those who had the highest rise in
serum 25(OH)D in response to supplementation) were compared to
non-responders (thosewith a limited increase in serum 25(OH)D in
response to supplementation), using methyl speciﬁc PCR. Sup-
porting the observations of Zhu et al., non-responders had higher
methylation of CYP2R1 at baseline and after supplementation, and
this may explain the reduced response to supplementation.
Following supplementation both responders and non-responders
exhibited reduced methylation levels of CYP24A1, suggesting
higher CYP24A1 expression may be a response to degrade the
additional supplemental vitamin D and maintain homeostasis [23].
This suggests that there is modiﬁcation of methylation status, and
that this may be both a cause and a response phenomenon,
depending on the situation. In the same study no differential
methylation was found for CYP27B1. In a validation study treating
plasma 25(OH)D levels as a continuous variable in independent
samples (n¼ 117 and 145), and using pyrosequencing to interrogate
individual CpGs, only a limited number of CpG sites upheld the
preliminary results following corrections for multiple testing.
Importantly, the validation cohort excluded the participants of the
two extremes (previously deﬁned as responders and non-
responders) used in the pilot study [23]. Additionally, relevance
of the methylation status at individual CpG sites is not yet fully
clear, compared to the broader methylation status across the CpG
island.
A limitation of these studies is minimal correction for other
dietary and lifestyle variables in the former study [19], and the use
of DNA found in serum in the latter [23]. Both cohorts are also of
limited size [19,23]. Vitamin D status may be modulated by a
number of variables including BMI, age, sex, and calcium intake in
addition to vitamin D intake and sun exposure [24]. Furthermore
DNA methylation status may be sensitive to cigarette smoking
status, alcohol intake, age, sex, and sun exposure [25,26]. Another
important consideration is that methylation potential may be
related to the availability of methyl donors resulting from the one
carbon metabolism cycle, and as such vitamin D metabolism may
be inﬂuenced by levels of methyl donor nutrients, such as folate
[27]. Therefore, in the current study we examined the relationship
between methylation status of vitamin D metabolism genes
(CYP2R1, CYP27B1 and CYP24A1) and VDR, plasma 25(OH)D status
and a number of dietary and lifestyle variables, including folate
status, in a mixed gender elderly cohort.
2. Methods
2.1. Subjects and sample collection
Participants for this study were 80 subjects drawn from a
completed cross-sectional study of 831 elderly participants (aged
65 years or more, 58.5% female) living on the Central Coast of NSW,
Australia (the Retirement Health and Lifestyle Study, RHLS). Details
of the selection and randomisation process are included in the
supplementary methods.
Whole blood was collected from participants and stored
at 20 C. Serum and plasma were stored at 80 C. DNA was
isolated from peripheral blood cells (PBCs) using Qiagen QIAmp
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including RNAse treatment. Written informed consent was ob-
tained from all participants. Approval was obtained from the Uni-
versity of Newcastle Human Research Ethics Committee (H-2008-
0431).
2.2. DNA methylation
Percentage DNA methylation was assessed at CpG sites across
CpG islands in CYP2R1, CYP27B1, CYP24A1, and VDR genes using
Qiagen EpiTect II methylation enzyme kits and PCR assays at the
concentrations and cycle conditions recommended by the manu-
facturer [28,29]. Details of the CpG island size, location and CpG
content are described in the supplementary methods
(Supplementary Table 1). This system uses selective digestion of
sample DNA with methylation-sensitive and methylation-
dependent restriction enzymes, followed by quantiﬁcation of the
remaining DNA by real-time PCR [28]. Details of the reaction con-
ditions and CpG sites assayed are included in the supplementary
methods.
2.3. Plasma 25(OH)D and homocysteine levels, and serum folate
and B12 levels
Plasma 25(OH)D levels weremeasured using a 25(OH)D vitamin
D ELISA kit for serum and plasma (Enzo Life Sciences, NY, USA),
according to the manufacturer's instructions [30]. Serum folate and
B12 levels were assessed by the Hunter Area Pathology Service
using standardised chemiluminescent laboratory protocols. A se-
lective ﬂuorescence assay and OP-162 homocysteine reader (Jei
Daniel (JD) Biotech Corp, Taipei, Taiwan) [31] was used to measure
plasma homocysteine [31,32].
2.4. Dietary and supplementary intake of vitamin D, calcium and
alcohol
Daily intake of vitamin D, calcium and alcohol were estimated
using food frequency questionnaires. Subjects also provided details
of all supplements and their frequency and dose of intake. Dietary
intake data were analysed using Foodworks™ (Version 2.10.146,
Xyris Software, Brisbane, QLD, Australia) [33e35].
2.5. Sun exposure: cumulative irradiance
Sample collection for this study was distributed over approxi-
mately a 10 month period from July 2010 to April 2011. As the in-
ﬂuence of seasonal differences in UV exposure on plasma 25(OH)D
levels is known to exhibit a 6e8 week lag [36,37], information on
the cumulative solar irradiance over the 6 weeks prior to sample
collection was collected [30] using NASA's Total Ozone Mapping
Spectrometer (TOMS) program via NASA's Aura OMI level 3 atmo-
spheric portal (http://gdata1.sci.gsfc.nasa.gov/daac-bin/G3/gui.cgi?
instance_id¼omi). Values (mW/m2/nm  103) were collected for
the location of the clinics for a wavelength of 305 nm (the
approximate wavelength of UVB responsible for the synthesis of
vitamin D in the skin) [38]. Where TOMS data for a speciﬁc datewas
invalid or unavailable, irradiancewas estimated by taking the mean
of the data taken for the time period a day before and after the date
[30].
2.6. Statistics
Statistical analyses were performed using JMP (Version 11, SAS
Institute Inc., Cary, NC, USA). Descriptive statistics (means, 95%
conﬁdence intervals, and range) were calculated and presented asappropriate. Where necessary, variables were transformed to
normalise distributions prior to regression analysis. Log(x) was
calculated for percentage methylation (expressed as proportions),
plasma 25(OH)D, calcium intake, vitamin D intake and plasma
homocysteine, and log (x þ 1) was calculated for alcohol (due to
zero values). The remaining variables were approximately normally
distributed. Standard least squares regression was used to assess
the relationships between multiple parameters and variables of
interest. All multivariable models were adjusted for age, sex, BMI,
cigarette smoking history, alcohol intake, and cumulative irradi-
ance. Adjusted R2 values and p-values are reported for ﬁnal models,
and standardised parameter estimates (b values) and p-values re-
ported for individual variables. Outcomes were considered to be
statistically signiﬁcant at p  0.05. p-values for interaction of terms
(pinteraction) were also calculated where appropriate.
3. Results
3.1. Percent methylation of CpG islands of vitamin D metabolism
genes in PBCs is low, but highly variable
At all CpG sites tested percentage methylation ranged dramat-
ically from almost fully unmethylated (0.01%) to almost fully
methylated (99.80%). However, the distributionwas heavily skewed
to lower methylation values, and therefore the averagemethylation
was low at all CpG sites (Fig. 2A) Percentage methylation values
(expressed as proportions) were transformed (log10(x)) to
approximately normalise the distribution for regression analyses
(Fig. 2B).
The descriptive statistics for the remaining variables (blood
measures, dietary and lifestyle) in this cohort are presented in
Table 1.
3.2. Percentage methylation status is not correlated between the
assessed CpG islands
The methylation statuses of the different sites were not related
to each other (Fig. 3). Only CYP2R1 and CYP24A1 were signiﬁcantly
positively related (r2 ¼ 0.17, p ¼ 0.0001).
3.3. Methylation of CpG islands in CYP2R1, CYP24A1 and VDR are
related to plasma 25(OH)D
In bivariate analyses, plasma 25(OH)D levels (log(x)) demon-
strated a weak negative correlation with CYP2R1 (r2 ¼ 0.05,
p ¼ 0.04) and CYP24A1 (r2 ¼ 0.06, p ¼ 0.02), and a positive corre-
lation with VDR (r2 ¼ 0.12, p ¼ 0.001). CYP27B1 methylation status
was not signiﬁcantly related to plasma 25(OH)D levels.
3.4. Methyl donor biochemistry does not inﬂuence the relationship
between plasma 25(OH)D and methylation, but may be an
independent predictor in some cases
As methylation potential may be inﬂuenced by methyl donor
availability [27,39], multivariable regression analysis was con-
ducted including serum folate, B12 and plasma homocysteine
(Table 2), three biochemical variables important in the folate
dependent one-carbon metabolism cycle. In the presence of these
additional variables, CYP2R1 and CYP24A1 methylation remained
negatively correlated to plasma 25(OH)D and VDR methylation
remained positively correlated (Table 2). However, while these re-
lationships were not altered the multi-variable modelling did
identify a potential role for serum folate and B12 in methylation
regulation at selected sites. Serum folate was positively related to
VDR methylation status, and B12 was positively correlated with
Fig. 2. Outlier box plots illustrating A) Percent methylation at each CpG island (raw data) and B) log10 transformed methylation status.
Table 1
Distribution of variables of interest in cohort.
Variable (units) Mean Lower Limit 95% CI Upper Limit 95% CI Range
Plasma vitamin D (ng/mL) 28.2 17.4 39.0 0.50e285.42
Serum folate (nmol/L) 27.2 24.9 29.4 8.8e55.3
Serum B12 (pmol/L) 240.8 216.7 265.0 83e604
Homocysteine (mM) 10.6 9.4 11.8 0.81e30.15
Vitamin D intake (mg/day) 5.5 4.0 7.0 0.23e28.6
Calcium intake (mg/day) 1020 917 1123 2.6e3.4
Age (years) 75.5 73.8 77.1 65e94
BMI (kg/m2) 28.9 27.8 30.1 20.3e42.8
Alcohol intake (g/day) 9.9 6.4 13.4 0e87.8
Cumulative irradiance (mW/m2/nm  103) 1890 1675 2124 404e3362
Smoker statusa 44%/56% N/A 17.4 N/A
CI ¼ conﬁdence interval.
a percent ever smokers/never smokers.
Fig. 3. Linear correlations between the methylation status of each CpG Island assessed.
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of the adjusted model, however, was only signiﬁcant for VDR
methylation status (Table 2).3.5. Methylation status of vitamin D metabolism enzyme genes may
explain some of the variance in the relationship between vitamin D
intake and plasma 25(OH)D levels
It has previously been reported that methylation status of
CYP2R1 and CYP24A1 are negatively associated with plasma 25(OH)
D levels in response to vitamin D supplementation [23]. Therefore,
we investigated the role of methylation status in predicting plasma
25(OH)D levels, corrected for total reported vitamin D intake and
other variables (calcium intake, age, sex, BMI, cigarette smoking
history, alcohol intake, and cumulative irradiance). Modelling all
methylation sites and adjustment variables together, resulted in a
model (R2 ¼ 0.54, p < 0.0001) with better predictive value for
plasma 25(OH)D than modelling without methylation status
included (R2 ¼ 0.46, p < 0.0001) or with vitamin D intake alone
(r2 ¼ 0.41, p < 0.0001). In the model including all variables, the
methylation status at CYP2R1 (b ¼ 0.20, p ¼ 0.026) was a signif-
icant independent negative predictor of plasma 25(OH)D, and VDR
(b¼ 0.26, p¼ 0.0046) was a signiﬁcant positive predictor of plasma
25(OH)D (Table 3). Modelling of the methylation status of the 4
genes alone signiﬁcantly predicted plasma 25(OH)D (R2 ¼ 0.18,
p ¼ 0.0008).
As vitamin D intake, calcium intake, and cumulative irradiance
may all individually contribute to plasma 25(OH)D levels, the in-
teractions between methylation status at each gene site and these
variables in predicting plasma 25(OH)D was assessed. pinteraction
values for each interaction are shown in Table 4. A signiﬁcant
interaction was found between the CYP2R1 methylation status and
vitamin D intake, calcium intake, and cumulative irradiance, in
Table 2
Multivariable regression analyses of the relationships between plasma 25(OH)D, serum folate, B12 and plasma homocysteinewithmethylation status of genes of key vitamin D
metabolism enzymes.
CYP2R1a CYB27B1a CYP24A1a VDRa
b p b P b p b P
Plasma 25(OH)Da ¡0.27 0.03 0.03 0.77 ¡0.33 0.04 0.25 0.03
Serum folate (nmol/L) 0.07 0.56 0.01 0.91 0.07 0.61 0.30 0.01
Serum B12 (pmol/L) 0.04 0.67 0.36 0.004 0.04 0.80 0.10 0.59
Homocysteine (mM)a 0.11 0.37 0.02 0.84 0.04 0.98 0.04 0.86
Model R2 (p-values) 0.003 (0.47) 0.03 (0.30) 0.04 (0.21) 0.21 (0.006)
Boldface highlights those variables that are statistically signiﬁcant.
a log(x) of raw values used in regression analysis. Analyses corrected for age, sex, BMI, cigarette smoking history, alcohol intake, and cumulative irradiance.
Table 3
Individual predictive value of DNAmethylation status for plasma 25(OH)D levels in a
model including all assessed methylation sites.
Methylation site Parameter estimate (b) p-value
CYP2R1 ¡0.20 0.03
CYP27B1 0.01 0.92
VDR 0.26 0.005
CYP24A1 0.02 0.79
Boldface highlights those variables that are statistically signiﬁcant; Analysis
adjusted for vitamin D and calcium intake, age, sex, BMI, cigarette smoking history,
alcohol intake, and cumulative irradiance.
Fig. 4. Potential points of methylation mediated regulation in the vitamin D meta-
bolism pathway. M ¼ methylation status, E ¼ hypothesised expression level.
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VDRmethylation status showed an interactionwith calcium intake,
but no interaction with vitamin D intake or cumulative irradiance
(Table 4). An interaction was found between CYP24A1 methylation
status and vitamin D intake (Table 4), despite there being no direct
association between CYP24A1 status and plasma 25(OH)D levels
(Table 3).4. Discussion
This research considers the relationship of plasma 25(OH)D
status, alone and in the context of vitamin D intake, with the
methylation status of vitamin D metabolism enzyme genes
(CYP2R1, CYP27B1 and CYP24A1) and VDR in a single cohort. Previ-
ous studies [19,23] on the relationship between DNA methylation
and vitamin Dmetabolism have not included VDR. Consideration of
VDR in addition to those enzymes directly involved in the meta-
bolism pathway is important, as complex feedback loops exist
involving the activated receptor.
Importantly, we have shown that when the methylation status
of all 4 genes is modelled together, methylation status alone pre-
dicts plasma vitamin D, explaining about 18% of variance, and im-
proves the predictive relationship of vitamin D intake on plasma
25(OH)D levels. In this model the methylation status of CYP2R1 and
VDR each remain independent signiﬁcantly predictive variables.
Additionally, this is the ﬁrst study to incorporate an analysis of the
inﬂuence of biochemical variables relevant to folate dependentTable 4
Statistical signiﬁcance of the interaction between methylation status and vitamin D inta
levels.
Methylation site pinteraction vitamin D intake  methylation pinteraction cal
CYP27B1 0.71 0.74
CYP2R1 0.0009 0.003
VDR 0.47 0.03
CYP24A1 0.04 0.62
Boldface highlights those variables that are statistically signiﬁcant; log(x) of raw valuesone-carbon metabolism, the origin of approximately half of the
methyl groups required for biochemical reactions.
A weak but signiﬁcant negative association was found between
CYP2R1 methylation status and plasma 25(OH)D status when
considered alone and in the context of vitamin D intake, supporting
the ﬁndings of the two previous studies [19,23]. These data are
further supported by the signiﬁcant interactions found between
CYP2R1 methylation status and the major determinants of plasma
25(OH)D levels, vitamin D intake, calcium intake and cumulative
irradiance. This may suggest that CYP2R1 methylation status is
modulating the contribution of these factors to the rise in plasma
25(OH)D levels (Fig. 4).
Similar to Zhou et al., but contradictory to Zhu et al., a negative
association was found between plasma 25(OH)D and CYP24A1
methylation. However, this relationship was lost when plasma
25(OH)D prediction was corrected for vitamin D intake. Assuming
the normal paradigm of reduced methylation increasing gene
expression, this may indicate that reduced methylation of CYP24A1
is a response to increased availability of vitamin D as a homeostatic
measure. The fact that the relationship between CYP24A1 methyl-
ation was lost when corrected for intake suggests that impaired
methylation is not the direct cause of plasma deﬁciency as pro-
posed by Zhu et al., but occurs in response to increased availabilityke, calcium intake and cumulative irradiance in the prediction of plasma 25(OH)D
cium intake  methylation pinteraction cumulative irradiance  methylation
0.94
0.009
0.86
0.41
used in regression analysis for all variables.
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Both previous studies found no relevant associations for
CYP27B1methylation [19,23]. Our data support these ﬁndings, with
no direct correlation found between CYP27B1 methylation and
plasma 25(OH)D, and no interaction found between plasma 25(OH)
D predicting variables and CYP27B1methylation. However, B12 was
identiﬁed as being potentially positively associated with CYP27B1
status, although with a small effect size. Additional studies are
required to determine if this association is functionally relevant and
identify other variables explaining the range of methylation found
at this CpG site. Potentially, CYP27B1 methylation and expression
may be modulated by 1,25(OH)D status, as this is the metabolite
produced by the enzyme.
This is the ﬁrst study, to our knowledge, to consider the rela-
tionship between VDR methylation status and plasma 25(OH)D
status. VDR methylation was positively associated with plasma
25(OH)D independently, and when considered in the context of
vitamin D intake, and when corrected for methyl donor biochem-
istry. Increased VDR methylation in response to increased plasma
25(OH)Dmay reﬂect a potential mechanism for a negative feedback
loop, where increased ligand availability decreases receptor
expression to maintain homeostasis of vitamin D signalling. Aber-
rant methylation in this pathway could therefore have conse-
quences for modulating risk of vitamin D sensitive diseases, and the
maintenance of calcium homeostasis.
This is the ﬁrst study to consider the role of methyl donor
biochemistry in the modulation of methylation in the genes of the
vitamin D metabolism pathway. Whilst the relationships noted
between plasma 25(OH)D and methylation status were maintained
when serum folate, B12 and plasma homocysteine levels were
included in the model, serum B12 was identiﬁed as positively
associated with CYP27B1 methylation status, and serum folate was
linked to VDR methylation. Although the effect size is small, given
their role in folate-dependent one-carbon metabolism, it is logical
that increased folate and B12 could result in increased methylation
via increased availability of methyl donors [31]. It is not clear how
or why this relationship would be speciﬁc to particular genes, thus
additional larger studies are required to conﬁrm or discount this
result. However, the lack of correlation between methyl-donor
biochemistry and CYP2R1 and CYP24A1, and the lack of correla-
tion between the percentage methylation of each assayed gene site
suggest that the results are not due to modulated global methyl-
ation, as is commonly suggested.
In this study, homocysteine was not related to the methylation
status of any gene assessed, however, given its position in the one-
carbon metabolism methylation cycle, changes in homocysteine
could be both a cause and a consequence of altered de novo
methylation, which may be confounding the analysis. The size of
the present study may mean this analysis is insensitive to these
effects in the context of the complex nature of the interactions
between the methyl-donor nutrients.
The hypothesised alterations in gene expression presented in
Fig. 4 are based on the standard paradigm of increased methylation
leading to decreased gene expression. It is important to note that
DNA methylation is only one part of the bigger gene regulation
picture, which includes other mechanisms such as histone
methylation, 5-hydroxymethylcytosines, and post-transcriptional
regulation. Additional studies are required to determine the
impact of this altered methylation on gene expression, and how
this regulatory mechanism interacts with others factors, including
genetic variance in the genes of interest, and variance in the genes
involved in maintenance of epigenetic marks.
A limitation of this study is the use of PBCs as the source of DNA
for methylation analysis. This may reduce the relevance of the re-
sults for CYP2R1, CYP27B1 and CYP24A1 as most of the actions ofthese enzymes occur in the liver and kidneys, and we cannot
directly relate the results presented here to these organs. This
might explain why no signiﬁcant relationship to plasma 25(OH)D
was found for CYP27B1. However, extra-renal and extra-hepatic
expression of these genes, including the expression of CYP2R1
[40], CYP27B1 [40,41] and CYP24A1 [40e42] has been demonstrated
in immune cells [40]. Additionally, increased expression of CYP24A1
has been demonstrated in PBCs following stimulation with
1,25(OH)D [41,42], and 25(OH)D production from precursors in
PBCs has also been demonstrated [41], indicating a potential
functional relevance of these genes in this tissue. VDR is ubiqui-
tously expressed, and has relevance to immune signalling path-
ways, however, it must be acknowledged that this result is not
necessarily transferable to other VDR expressing organs. Despite
the lack of generalisability, regulation of these enzymes in PBCs
may contribute to the overall regulation of this pathway, or may be
reﬂective of its status in other organs.
Additionally, while we have attempted to correct for sun-
exposure, due to its potential inﬂuence on both vitamin D syn-
thesis and methylation, the precision of the cumulative irradiance
measurements used only takes into account location exposure for
the time of year of collection, and does not factor in each in-
dividuals time spent outdoors, clothing habits, use of sunscreen and
other potential modulating factors. Unfortunately, due to the na-
ture of the original study from which this cohort was drawn, this
informationwas not available. It is also important to note this study
was conducted in an elderly cohort. Whilst this result is therefore
not automatically generalizable to all age groups, synthesis of
vitamin D in the skin is reduced in the elderly (due to lifestyle
changes and reduced precursor availability) and intake from di-
etary and supplementary sources is therefore a more important
contributor.
Whilst the sample size is also a potential limitation, it is
signiﬁcantly larger than those used by Zhu et al. [19], and in the
Zhou et al. [23] pilot study, and similarly sized relative to the
validation study conducted by Zhou et al. [23]. Numerous methods
are available for the assessment of methylation at CpG islands. The
EpiTect II assays are more sensitive than methylation arrays, and
more accurate than methylation speciﬁc PCR (MSP) [28]. The CpG
Islands assessed in the current study span the same regions as the
MSP conducted by Zhou et al. [23], and the methylation array
conducted by Zhu et al. [19], for CYP2R1 and CYP24A1. For CYP27B1
the CpG Island assessed by the Epitect II assay is located further
away from the transcription start site from that assayed using MSP
by Zhou et al. [23]. However, advantage of the present study is that
the Epitect II assays represent density of methylation across the
assayed CpG Island, on a continuous scale.Whereas, by comparison,
MSP only compares fully methylated versus fully unmethylated
DNA in the primer regions [23].
While bisulﬁte conversion and sequencing used in the valida-
tion study by Zhou et al. [23] is far more detailed, the lack of un-
derstanding of the role of methylation at individual CpG sites, as
opposed to the island in general, means this level of detail may be
excessive at this stage. Sequencing is also far more expensive than
enzyme based methods, as such, the sequencing for CYP2R1 and
CYP24A1 conducted in the conﬁrmation study by Zhou et al.,
covered only 14e16 CpG sites. Therefore although the enzyme
based method presented here does not achieve single base reso-
lution, assessment of percentage methylation (methylation den-
sity) allows assessment across a larger range.
In summary, this study has conﬁrmed the inverse association
between CYP2R1 methylation status and plasma 25(OH)D, and
conﬁrmed the lack of association for CYP27B1. As the association
between plasma 25(OH)D and CYP24A1 is only apparent in the
absence of correction for vitamin D intake, this supports the
E.L. Beckett et al. / Journal of Nutrition & Intermediary Metabolism 6 (2016) 8e1514hypothesis that altered CYP24A1 methylation occurs in response to
plasma 25(OH)D levels, rather than methylation status being an
explanatory factor for deﬁciency as previously hypothesised.
We have extended the understanding of the role of methylation
in this pathway by demonstrating, for the ﬁrst time, a positive as-
sociation between VDRmethylation and plasma 25(OH)D. This may
contribute to the broader understanding of the maintenance of
vitamin D and calcium homeostasis, and the role that aberration of
this pathway could play in disease. Additionally, we have identiﬁed
a potential limited role for methyl-donor biochemistry as an in-
dependent predictor of CYP27B1 and VDR methylation, without
modiﬁcation of the plasma 25(OH)D effect. The gene speciﬁcity of
this relationship and the consequences of excess, deﬁciency or
supplementation of these factors should be further investigated.
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